Chemed Corporation $CHE Shares Acquired by M&T Bank Corp

M&T Bank Corp lifted its stake in shares of Chemed Corporation (NYSE:CHE) by 10,291.1% during the fourth quarter, Holdings Channel reports. The firm owned 85,934 shares of the company’s stock after buying an additional 85,107 shares during the period. M&T Bank Corp’s holdings in Chemed were worth $36,768,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Alps Advisors Inc. grew its holdings in Chemed by 32.4% in the 3rd quarter. Alps Advisors Inc. now owns 44,295 shares of the company’s stock worth $19,833,000 after buying an additional 10,845 shares in the last quarter. Vest Financial LLC grew its holdings in Chemed by 32.6% in the 3rd quarter. Vest Financial LLC now owns 9,702 shares of the company’s stock worth $4,344,000 after buying an additional 2,383 shares in the last quarter. SG Americas Securities LLC grew its holdings in Chemed by 773.5% in the 4th quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock worth $11,324,000 after buying an additional 23,436 shares in the last quarter. Van Berkom & Associates Inc. grew its holdings in Chemed by 33.0% in the 3rd quarter. Van Berkom & Associates Inc. now owns 170,813 shares of the company’s stock worth $76,480,000 after buying an additional 42,390 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its holdings in Chemed by 6.5% in the 3rd quarter. Envestnet Asset Management Inc. now owns 80,080 shares of the company’s stock worth $35,855,000 after buying an additional 4,865 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Stock Performance

Shares of NYSE CHE opened at $373.15 on Thursday. The stock has a fifty day moving average price of $405.82 and a two-hundred day moving average price of $426.70. The firm has a market cap of $5.45 billion, a P/E ratio of 20.31, a PEG ratio of 1.48 and a beta of 0.49. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $593.80.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). The firm had revenue of $639.34 million for the quarter, compared to the consensus estimate of $659.09 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. The business’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period in the previous year, the business posted $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, research analysts predict that Chemed Corporation will post 21.92 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is presently 13.06%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on CHE shares. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Oppenheimer decreased their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $422.00 price objective (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Weiss Ratings lowered Chemed from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, April 13th. Finally, Zacks Research lowered Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $498.00.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the transaction, the chief executive officer directly owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. This trade represents a 2.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 3.29% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.